| Warfarin Sodium Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Warfarin Sodium 4 mg | tablet | oral | 1.0 each | OTC |
| Warfarin Sodium 10 mg | tablet | oral | 1.0 each | OTC |
| Warfarin Sodium 1 mg | tablet | oral | 1.0 each | OTC |
| Warfarin Sodium 2 mg | tablet | oral | 1.0 each | OTC |
| Warfarin Sodium 3 mg | tablet | oral | 1.0 each | OTC |
| Warfarin Sodium 5 mg | tablet | oral | 1.0 each | OTC |
| Warfarin Sodium 6 mg | tablet | oral | 1.0 each | OTC |
| Warfarin Sodium 2.5 mg | tablet | oral | 1.0 each | OTC |
| Warfarin Sodium 7.5 mg | tablet | oral | 1.0 each | OTC |
| Warfarin Sodium - | powder | compounding | 100.0 gram(s) | OTC |
Posted by editha1953 16 days ago
Doctors really kind of hit and miss w/ all these agenda of telling patients that coumadin related symptoms are not at all wha...
Posted by marianring 17 days ago
I started coumadin 2 weeks ago, for a clot in my leg. I'm dizzy and lightheaded. I guess I'll be on it for at least 3 months....
Posted by stormie64 29 days ago
I was diagnosed with Factor V Leiden after suffering from bilateral PEs in February 2004. I am on Warfarin for the rest of my...
FDA Grants Priority Review for ACIPHEX(R) (rabeprazole sodium ... - Earthtimes
Patients on warfarin (such as Coumadin(R)) may need to be monitored more closely by their doctor. To learn more, talk to your doctor and see the full ...
Fri Feb 29 17:59:23 -0500 2008
China blacklists 141 seriously polluting products - Xinhua
The list included products closely linked to people's daily life, such as warfarin, mirex, DDT and nickel-cadmium cell, said Pan Yue, State Environmental ...
Tue Feb 26 07:20:03 -0500 2008
China blacklists 141 seriously polluting products - People's Daily Online
The list included products closely linked to people's daily life, such as warfarin, mirex, DDT and nickel-cadmium cell, said Pan Yue, State Environmental ...
Tue Feb 26 08:16:05 -0500 2008
warfarin sodium - The sodium salt form of warfarin, a coumarin and a vitamin K antagonist, with anticoagulant activity. Warfarin sodium inhibits both vitamin K and vitamin K epoxide reductases, thereby interfering with the cyclic interconversion of vitamin K epoxide to its reduced form, vitamin KH2. Vitamin KH2 is a cofactor for the carboxylation of glutamate residues on the N-terminal regions of vitamin K-dependent proteins. As a result, maturation of vitamin K-dependent coagulation factors II, VII, IX, and X and anticoagulant proteins C and S is inhibited. Without these coagulation factors, thrombogenesis and blood clot formation are prevented.